Why the study?
Pulmonary rehabilitation remains highly inaccessible due to poor awareness, low referral, and hospital-based delivery, requiring novel delivery models to enhance implementation while maintaining cost-efficiency.
Does a 12-week community-based pulmonary rehabilitation programme improve health-related quality of life in patients with chronic respiratory diseases and their caregivers?
Population
73 patients with CRD and their caregivers in the experimental group alongside matched control dyads
Comparison
12-week community-based pulmonary rehabilitation programme vs matched dyads not receiving PR
Design
Controlled trial protocol with cost-benefit analysis
Follow-up
6-months post-PR
Authors
Loading...
Community-based PR may enhance access and cost-efficiency; leaves open whether real-world implementation yields net clinical or economic gains versus standard models.
Does a 12-week community-based pulmonary rehabilitation programme improve health-related quality of life in patients with chronic respiratory diseases and their caregivers?
This study protocol outlines a non-randomized controlled trial to evaluate the clinical and cost-effectiveness of a 12-week community-based pulmonary rehabilitation program for patients with chronic respiratory diseases and their caregivers.
Marques et al. (2019) studied this question.